Consensus Forecasts
April 2012
Consensus compiled by Vara from forecasts by 29 analysts.
2012
|
| $ |
High |
Mean |
Low |
| Sales |
14'620m |
14'217m |
13'723m |
| EBITDA* |
3'411m |
3'228m |
3'040m |
| Net Income |
2'083 m |
1'837 m |
1'700m |
| Earnings per share (EPS)** |
24.21 |
21.88 |
19.84 |
2013
|
| $ |
High |
Mean |
Low |
| Sales |
16'017m |
15'051m |
14'259m |
| EBITDA* |
3'784 m |
3'492m |
3'254m |
| Net Income |
2'419m |
2'127m |
1'868m |
| Earnings per share (EPS)** |
28.27 |
24.29 |
21.71 |
* excluding restructuring and impairment
** EPS on a fully-diluted basis, excluding restructuring and impairment
2012 Outlook
In 2012, we expect sustained sales growth and further market share gains.
|
| CHF |
High |
Mean |
Low |
| |
410 |
333 |
265 |
Analysts Covering Syngenta
The following list* includes institutions that publish regular research reports on Syngenta. Their reports have been used to create the consensus forecast included above.
|
| Institution |
Analyst |
| Bank am Bellevue |
Bruno Eschli |
| Bank of America Merrill Lynch |
Andrew Stott |
| Berenberg Bank |
Jaideep Pandya |
| Bernstein |
Jeremy Redenius |
| BZ Bank Aktiengesellschaft |
Eric Bonvin |
| CA Cheuvreux |
Martin Roediger |
| Citigroup |
Andrew Benson |
| Collins Stewart |
Paul Satchell |
| Credit Suisse |
Rhian Tucker |
| Deutsche Bank |
Virginie Boucher-Ferte |
| DZ Bank |
Heinz Müller |
| Exane BNP Paribas |
Heidi Vesterinen / James Knight |
| Gilford Securities |
Paul Christopherson |
| Goldman Sachs |
Richard Logan |
| HSBC |
Geoff Haire |
| J.P. Morgan |
Neil Tyler, Martin Evans |
| Kepler Capital Markets |
Bettina Edmondston |
| Macquarie equities research |
Juergen Reck |
| Main First Bank AG |
Ronald Köhler |
| Morgan Stanley |
Paul Walsh |
| Nomura |
Jean De Watteville |
| Redburn Partners |
Tony Jones |
| Societe Generale |
Patrick Lambert |
| UBS |
Thomas Gilbert |
| Liberum |
Sophie Jordier |
| Vontobel |
Patrick Rafaisz |
| Jefferies |
Lucy Watson |
| Equita |
Massimo Bonisoli |
| ING |
Fabian Smeets |
* The above list is a selection of analysts currently covering Syngenta. We do not make any claim that this list is comprehensive of all institutions publishing regular research reports on Syngenta.
Disclaimer
Any opinions, forecasts, estimates, projections or predictions regarding Syngenta's performance made by the analysts are theirs alone and do not represent the opinions, forecasts, estimates, projections or predictions of Syngenta. By providing these names, Syngenta does not imply its endorsement of or concurrence with their reports, conclusions or recommendations and Syngenta does not assume any liability for the accuracy of the information.
Please note that this list does not constitute a solicitation to buy, hold or sell securities.